Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HUYA Appoints Vice President Of Commercial Planning

This article was originally published in Scrip

Executive Summary

HUYA Bioscience International has appointed Scott Garrett vice president, commercial planning. Scott brings over 20 years of commercial experience in drugs and devices for oncology and cardiovascular disease and he previously held positions in companies such as Celladon, Mallinckrodt, Gilead, Johnson and Johnson, Boston Scientific and Nycomed Amersham (now GE Healthcare). His previous responsibilities include sales and marketing, commercial planning, product launch, healthcare economics, reimbursement, advocacy development, life cycle management and business development for brands such as Ceretec, Taxus, Natrecor, Ranexa and Ofirmev.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts